nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ABC: a novel algorithm to stratify decompensation risk in patients with compensated advanced chronic liver disease (CHESS2108): an international, multicenter cohort study
|
Liu, Chuan |
|
|
16 |
5 |
p. 1105-1115 |
artikel |
2 |
Acute variceal bleeding portends poor outcomes in patients with acute-on-chronic liver failure: a propensity score matched study from the APASL ACLF Research Consortium (AARC)
|
Sharma, Sanchit |
|
|
16 |
5 |
p. 1234-1243 |
artikel |
3 |
A deep learning model with incorporation of microvascular invasion area as a factor in predicting prognosis of hepatocellular carcinoma after R0 hepatectomy
|
Wang, Kang |
|
|
16 |
5 |
p. 1188-1198 |
artikel |
4 |
A somatic mutation-derived LncRNA signatures of genomic instability predicts the prognosis and tumor microenvironment immune characters in hepatocellular carcinoma
|
Jin, Chuan |
|
|
16 |
5 |
p. 1220-1233 |
artikel |
5 |
Aspirin for patients after TIPS: an old dog with new tricks?
|
Wang, Jitao |
|
|
16 |
5 |
p. 1244-1245 |
artikel |
6 |
Combining stereotactic body radiotherapy with camrelizumab for unresectable hepatocellular carcinoma: a single-arm trial
|
Li, Jian-Xu |
|
|
16 |
5 |
p. 1179-1187 |
artikel |
7 |
CT-based visual grading system for assessment of hepatic steatosis: diagnostic performance and interobserver agreement
|
Park, Hyo Jung |
|
|
16 |
5 |
p. 1075-1084 |
artikel |
8 |
Direct antiviral therapy for hepatitis C cirrhotic patients in liver transplantation settings: a systematic review
|
Li, Jonathan |
|
|
16 |
5 |
p. 1020-1031 |
artikel |
9 |
Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study
|
Tan, Natassia |
|
|
16 |
5 |
p. 1094-1104 |
artikel |
10 |
G-CSF treatment in decompensated liver disease: a double-edged sword?
|
Engelmann, Cornelius |
|
|
16 |
5 |
p. 979-982 |
artikel |
11 |
Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study
|
Su, Ke |
|
|
16 |
5 |
p. 1208-1219 |
artikel |
12 |
Is laparoscopic hepatectomy superior to laparotomic hepatectomy? The debate continues
|
Zheng, Yitao |
|
|
16 |
5 |
p. 1250-1251 |
artikel |
13 |
Lenvatinib for the treatment of hepatocellular carcinoma—a real-world multicenter Australian cohort study
|
Patwala, Kurvi |
|
|
16 |
5 |
p. 1170-1178 |
artikel |
14 |
Letter to the editor: Treating portal vein thrombosis in cirrhosis: is anticoagulation therapy overestimated?
|
Wang, Xiaobing |
|
|
16 |
5 |
p. 1248-1249 |
artikel |
15 |
Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain
|
Ramos-Rincon, José-Manuel |
|
|
16 |
5 |
p. 1161-1169 |
artikel |
16 |
Liver transplantation in patients with acute-on-chronic liver failure
|
Lanke, Gandhi |
|
|
16 |
5 |
p. 993-1000 |
artikel |
17 |
Low platelets: a new and simple prognostic marker for patients with hepatitis E virus-related acute liver failure
|
Mu, Xiuying |
|
|
16 |
5 |
p. 1116-1126 |
artikel |
18 |
Low skeletal muscle mass is associated with more severe histological features of non-alcoholic fatty liver disease in male
|
Pan, Xiao-Yan |
|
|
16 |
5 |
p. 1085-1093 |
artikel |
19 |
MAFLD, patient-centred care, and APASL
|
Sarin, Shiv K. |
|
|
16 |
5 |
p. 1032-1034 |
artikel |
20 |
Management of spontaneous portosystemic shunts at the time of liver transplantation: treatment or observation? Results of a systematic review
|
Cusumano, Caterina |
|
|
16 |
5 |
p. 983-992 |
artikel |
21 |
Multiple cycles of granulocyte colony-stimulating factor in decompensated cirrhosis: a double-blind RCT
|
Venkitaraman, Aswath |
|
|
16 |
5 |
p. 1127-1136 |
artikel |
22 |
Non-invasive evaluation of NAFLD and the contribution of genes: an MRI-PDFF-based cross-sectional study
|
Yang, Aruhan |
|
|
16 |
5 |
p. 1035-1051 |
artikel |
23 |
Pan-genotypic direct-acting antivirals for patients with hepatitis C virus infection and chronic kidney disease stage 4 or 5
|
Liu, Chen-Hua |
|
|
16 |
5 |
p. 1001-1019 |
artikel |
24 |
Prognosis and treatment pattern of advanced hepatocellular carcinoma after failure of first-line atezolizumab and bevacizumab treatment
|
Chen, Ching-Tso |
|
|
16 |
5 |
p. 1199-1207 |
artikel |
25 |
Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective study
|
Hatanaka, Takeshi |
|
|
16 |
5 |
p. 1150-1160 |
artikel |
26 |
Response to: Aspirin for patients after TIPS. An old dog with new tricks?
|
Seifert, Leon Louis |
|
|
16 |
5 |
p. 1246-1247 |
artikel |
27 |
Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease
|
Kong, Yuanyuan |
|
|
16 |
5 |
p. 1052-1063 |
artikel |
28 |
The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma
|
Chiang, Nai-Jung |
|
|
16 |
5 |
p. 1137-1149 |
artikel |
29 |
The regulation effect of GLUT9/SLC2A9 on intrahepatic uric acid level and metabolic associated fatty liver disease
|
Zeng, Hang |
|
|
16 |
5 |
p. 1064-1074 |
artikel |